Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USAUnited States
Also available as PDF (figures and tables appear in the PDF).
Pancreatic islets of Langerhans are cell clusters that play a key role in glucose homeostasis. Among the five hormone secret-ingislet endocrine cells (insulin secreting β-cells, glucagon secret-ing α-cells, somatostatin secreting δ-cells, pancreatic polypeptide secreting PP-cells, and ghrelin secreting ε-cells), β-cells are special-ized glucose sensors that respond to increased insulin demand dur-ing physiological (i.e. pregnancy) or pathophysiological (i.e. type 2 diabetes) conditions.
Keywords: insulin secreting β-cells, glucagon secret-ing α-cells, somatostatin secreting δ-cells, pancreatic polypeptide secreting PP-cells, and ghrelin secreting ε-cells
PANCREAS PUBLISHERS ISSN 2471-142X Open Journal Ercument Dirice, PhD* Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, MA, USA *Corresponding author Ercument Dirice, PhD Research Associate, Joslin Diabetes Center-Instructor, Harvard Medical School, Boston, MA, USA; E-mail: ercument.dirice@joslin.harvard.edu Article information Received: August 20th, 2018; Accepted: September 7th, 2018; Published: September 7th, 2018 Cite this article Dirice E. ß-cell heterogeneity: The key to ß-cell replacement therapy. Pancreas Open J. 2018; 2(1): e10-e11. doi: 10.17140/POJ-2-e009 β-cell Heterogeneity: The Key to β-cell Replacement Therapy Editorial | Volume 2 | Number 1| e10 Copyright 2018 by Dirice E. This is an open-access article distributed under Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows to copy, redistribute, remix, transform, and reproduce in any medium or format, even commercially, provided the original work is properly cited. cc “It is not the strongest of the species that survives, nor the most intelligent that survives. It is the one that is most adaptable to change” (Charles Darwin – The Origin of Species, 1859) C ellular heterogeneity is crucial for organisms to adapt to their environmental changes. It provides the morphological, func - tional and molecular diversity that allows tissues and organs to re- spond to stressors and maintain cell integrity.
Pancreatic islets of Langerhans are cell clusters that play a key role in glucose homeostasis. Among the five hormone secret- ingislet endocrine cells (insulin secreting β-cells, glucagon secret - ing α-cells, somatostatin secreting δ-cells, pancreatic polypeptide secreting PP-cells, and ghrelin secreting ε-cells), β-cells are special- ized glucose sensors that respond to increased insulin demand dur- ing physiological (i.e. pregnancy) or pathophysiological (i.e. type 2 diabetes) conditions.1-3 Since the 1960s, rodent and human studies have shown that seemingly identical β-cells can be grouped into morphologi - cal and functional subtypes.4-8 For instance, a recent study in mice reported that proliferative and mature β-cells can be distinguished by their expression of Flattop.9 Another study in mice, grouped a minor β-cell population (1-10%) as hub cells being different from non-hub (follower) cells by their electrical-coupling capacity result- ing in an organized insulin secretion. 10 Understanding the mecha- nisms behind β-cell heterogeneity within or between islets can also be used as a therapeutic approach for β-cell survival. Indeed, a group of novel β-cells with lower granularity and stem-like feature has been reported to be protected during type 1 diabetes develop- ment.11 In parallel to rodent studies, several groups identified hu- man β-cell subtypes by using technological advances. For instance, by using CyTOF to study at a single cell level, β-cells from mul- tiple donors were grouped into three main populations based on their proliferation, maturation and several reported heterogeneity markers.12 On the other hand, Dorrell et al identified four distinct β-cell subpopulations based on their cell surface markers (CD9 and ST8SA1) which were developed by the same group.13 Nevertheless, the exact landscape of β-cell heterogeneity, including its functional and molecular significance, is incompletely understood.
Since type 1 (T1D) and type 2 diabetes (T2D) is marked by insufficient functional β-cell mass, there has been an increasing effort to develop β-cell replacement therapies. A promising strate- gy is to stimulate β-cell proliferation through small molecules, such as DYRK1A and TGF-β1 inhibitors.14-16 Moreover, important ad- vancements have been made to generate β-cells from other cell lin- eages, such as other pancreatic islet cells, pancreatic duct cells, and stem cells.17-19 However, understanding β-cell heterogeneity will be paramount to strengthening these approaches. Specifically, identi - fying and expanding β-cell subpopulations that are resistant to ex- ogenous stressors (immune cells, high glucose, etc.) or primed for proliferation can provide a long-lasting therapeutic effect for T1D and T2D. To this end, several questions have yet to be answered: 1) What are the factors that influence heterogeneity of β-cells?
2) What is the origin of β-cell heterogeneity?
3) Does β-cell heterogeneity exist within islets or between islets or both?
4) How similar are β-cell subpopulations between rodents and humans?
5) Are specific β-cell subpopulations protected from stress- mediated cell death in T1D and T2D?
Editorial Pancreas Open J. 2018; 2(1): e10-e11. doi: 10.17140/POJ-2-e009 PUBLISHERS Dirice E While recent studies have increased our understanding of β-cell heterogeneity, we need to further harness technological advances and smart study designs to characterize and exploit β-cell heterogeneity in therapies for T1D and T2D.